Showing results (91-100 of 99) with videos related to

Sort By:
Pageof 10
You have reached the last page of results.This site can display upto 99 results.
Alzheimer'S & Dementia : the Journal of the Alzheimer'S Association|November 14, 2022
A public resource of baseline data from the Alzheimer's Prevention Initiative Autosomal-Dominant Alzheimer's Disease TrialEric M Reiman, Jeremy J Pruzin, Silvia Rios-Romenets, et al.
Alzheimer'S & Dementia (Amsterdam, Netherlands)|September 20, 2021
Cortical thickness across the lifespan in a Colombian cohort with autosomal-dominant Alzheimer's disease: A cross-sectional studyJoshua T Fox-Fuller, Heirangi Torrico-Teave, Federico d'Oleire Uquillas, et al.
Cell Metabolism|October 2, 2021
Hyperglycemia in acute COVID-19 is characterized by insulin resistance and adipose tissue infectivity by SARS-CoV-2Moritz Reiterer, Mangala Rajan, Nicolás Gómez-Banoy, et al.
The American Journal of Pathology|April 26, 2022
Angiopoietin 2 Is Associated with Vascular Necroptosis Induction in Coronavirus Disease 2019 Acute Respiratory Distress SyndromeDavid R Price, Elisa Benedetti, Katherine L Hoffman, et al.
Neuroimage. Clinical|July 12, 2021
PET evidence of preclinical cerebellar amyloid plaque deposition in autosomal dominant Alzheimer's disease-causing Presenilin-1 E280A mutation carriersValentina Ghisays, Francisco Lopera, Dhruman D Goradia, et al.
Alzheimer'S Research & Therapy|January 16, 2021
Longitudinal amyloid and tau accumulation in autosomal dominant Alzheimer's disease: findings from the Colombia-Boston (COLBOS) biomarker studyJustin S Sanchez, Bernard J Hanseeuw, Francisco Lopera, et al.
Alzheimer'S & Dementia : the Journal of the Alzheimer'S Association|February 1, 2022
Sex differences in cognitive resilience in preclinical autosomal-dominant Alzheimer's disease carriers and non-carriers: Baseline findings from the API ADAD Colombia TrialClara Vila-Castelar, Pierre N Tariot, Kaycee M Sink, et al.
The Lancet. Neurology|January 24, 2026
Safety and efficacy of crenezumab in cognitively unimpaired carriers of the PSEN1<sup>Glu280Ala</sup> mutation at risk for autosomal-dominant Alzheimer's disease in Colombia (API ADAD Colombia Trial): a phase 2, randomised, double-blind, placebo-controlled trialPierre N Tariot, Francisco S Lopera, Silvia Ríos-Romenets, et al.
Cell|August 19, 2023
Epigenetic memory of coronavirus infection in innate immune cells and their progenitorsJin-Gyu Cheong, Arjun Ravishankar, Siddhartha Sharma, et al.
Pageof 10